Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Fixed Capital/Sales

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

NGL FINECHEM Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.500.420.480.360.36

What is the latest Fixed Capital/Sales ratio of NGL FINECHEM ?

The latest Fixed Capital/Sales ratio of NGL FINECHEM is 0.50 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.50
Mar20240.42
Mar20230.48
Mar20220.36
Mar20210.36

How is Fixed Capital/Sales of NGL FINECHEM Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.5
19.05
Mar2024 0.42
-12.50
Mar2023 0.48
33.33
Mar2022 0.36
0.00
Mar2021 0.36 -

Other Financial Ratios of NGL FINECHEM


Compare Fixed Capital/Sales ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,438.7 Cr 3.6% 52.1% 79.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,717.0 Cr 0.6% 7% 1.4% Stock Analytics
DIVIS LABORATORIES ₹166,830.0 Cr 1.6% 4.6% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,479.0 Cr 3.1% 5.9% 39% Stock Analytics
CIPLA ₹108,978.0 Cr 1.5% -2.1% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,905.0 Cr 0.5% 9.8% 5.7% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

3.6%

52.1%

79.7%

SENSEX

-0.6%

0.6%

9.8%


You may also like the below Video Courses